Nomic Bio
YC W20Montreal, CA · Founded 2017 · 24 employees · Hiring · 11 known investors
Find your way into Nomic Bio
Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.
Also known as nplex biosciences
Founders & leadership· Y Combinator alumni (W20)
Nomic Bio was founded in 2017 by Milad Dagher and Jeff Munzar.
Investors · 11
Avant BioNew York
First Star VenturesCambridge · $100K – $1M
Front Row VenturesMontreal
Raptor GroupMiami Beachvia James J. Pallotta · inferred
Y CombinatorSan Francisco · $500K
2048 VenturesreportedNew York · $500K – $3M
BoxOne VenturesreportedMontréal · $500K
Casdin CapitalreportedNew York
Lux Capitalreported · 2 sourcesNew York · $100K – $100M
Also in the syndicate · 2
SR OneYCombinator
Funding
SEC filings, press & company announcements$42M disclosed across 1 of 2 rounds · 2021–2024
- $42MSeries BSep 2024 · 3 sourcesSource ↗
- Undisclosed amountSeries ADec 2021
Lux Capital (lead), 2048 Ventures, Casdin Capital, Real Ventures, SR One, YCombinator
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Nomic Bio went on to found or lead other companies.
Competitors · 5
by search overlap
Phenomic AI14 shared keywordsPhenomic AI is a biotech company developing therapies for solid tumors using a machine-learning-powered transcriptomics platform that analyzes single-cell RNA data to identify drug targets and understand tumor biology. The company develops antibody-based therapies informed by its analysis of cell-cell interactions in tumor microenvironments, with current programs targeting stromal and immune components of difficult-to-treat cancers.
IDbyDNA12 shared keywordsScalable, high throughput DNA sequencing platforms.
NeoGenomics10 shared keywordsNeoGenomics develops diagnostic tests and tools for cancer care, including tests for immunotherapy response monitoring, therapy selection, and minimal residual disease detection.
Genomics Plc9 shared keywordsGenomics builds a genotype-phenotype database and genetic risk-prediction tools used to support pharmaceutical drug discovery and clinical trials, as well as population health management and clinical decision support for healthcare providers. It serves life sciences companies and healthcare systems through its Life Sciences and Health & Wellness divisions.
Verinomics9 shared keywordsVerinomics develops crop improvement technology by combining genomics, computational biology, and a transgene-free gene editing platform, with an AI-driven population genomics tool to identify high-value trait genes. It serves breeding programs, agricultural businesses, and research institutions focused on specialty and vegetatively propagated crops such as leafy greens.
Companies competing with Nomic Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Nomic Bio do?
- Nomic offers an end-to-end protein profiling service built on its nELISA technology, quantifying up to 1000 informative proteins with absolute quantification for research studies. It targets researchers doing proteomics work, aiming for high-throughput, low-cost profiling in the biotech and life sciences market.
- Who founded Nomic Bio?
- Nomic Bio was founded by Milad Dagher, Jeff Munzar in 2017.
- Who are Nomic Bio's investors?
- Nomic Bio's investors include Avant Bio, First Star Ventures, Front Row Ventures, Raptor Group, Y Combinator, 2048 Ventures, BoxOne Ventures, Casdin Capital and 1 more.
- How much funding has Nomic Bio raised?
- Nomic Bio has disclosed $42M raised across 1 of its 2 known rounds.
- Where is Nomic Bio headquartered?
- Nomic Bio is headquartered in Montreal, CA.